Management of epilepsy in the community.
dc.contributor.author | Neligan, A | |
dc.contributor.author | Renganathan, R | |
dc.contributor.author | Sweeney, B J | |
dc.date.accessioned | 2012-02-03T15:05:36Z | |
dc.date.available | 2012-02-03T15:05:36Z | |
dc.date.issued | 2012-02-03T15:05:36Z | |
dc.identifier.citation | Ir Med J. 2006 Feb;99(2):52-4. | en_GB |
dc.identifier.issn | 0332-3102 (Print) | en_GB |
dc.identifier.issn | 0332-3102 (Linking) | en_GB |
dc.identifier.pmid | 16548222 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10147/208856 | |
dc.description.abstract | We posted a questionnaire on epilepsy to all 375 GPs in Cork and Kerry (population 500,000) The questionnaire consisted of 10 sections, covering areas like GP demographics, initial referral practice following a first seizure, advice given to patients and GP's attitudes towards patients with epilepsy. The main focus of the study was GP awareness of 7 of the newer anti-epileptics and their side effects. There was a response rate of 46.7% (175) and revealed that the majority (87%) initially refer patients to a neurologist for further assessment. The majority of GPs gave patients advice about driving, AED side effects, interaction with the OCP and pregnancy counselling. GP awareness of the newer anti-epileptics is very variable with Gabapentin and Lamotrigine having the highest GP awareness rates. Almost 25% of GPs would initiate treatment following a first time seizure although only 30% would change therapy initiated by a consultant neurologist. Finally the majority of GPs were unhappy with the level of access to neurologists and 95% of GPs felt that the provision of an Epilepsy Clinical Nurse Specialist would help alleviate the problem. | |
dc.language.iso | eng | en_GB |
dc.subject.mesh | Clinical Competence/statistics & numerical data | en_GB |
dc.subject.mesh | Community Health Services | en_GB |
dc.subject.mesh | Epilepsy/*therapy | en_GB |
dc.subject.mesh | *Family Practice | en_GB |
dc.subject.mesh | Female | en_GB |
dc.subject.mesh | Humans | en_GB |
dc.subject.mesh | Ireland | en_GB |
dc.subject.mesh | Male | en_GB |
dc.subject.mesh | Referral and Consultation | en_GB |
dc.title | Management of epilepsy in the community. | en_GB |
dc.contributor.department | Department of Neuroscience, Cork University Hospital, Cork. aidan60@yahoo.com | en_GB |
dc.identifier.journal | Irish medical journal | en_GB |
dc.description.province | Munster | |
refterms.dateFOA | 2023-09-05T11:23:17Z | |
html.description.abstract | We posted a questionnaire on epilepsy to all 375 GPs in Cork and Kerry (population 500,000) The questionnaire consisted of 10 sections, covering areas like GP demographics, initial referral practice following a first seizure, advice given to patients and GP's attitudes towards patients with epilepsy. The main focus of the study was GP awareness of 7 of the newer anti-epileptics and their side effects. There was a response rate of 46.7% (175) and revealed that the majority (87%) initially refer patients to a neurologist for further assessment. The majority of GPs gave patients advice about driving, AED side effects, interaction with the OCP and pregnancy counselling. GP awareness of the newer anti-epileptics is very variable with Gabapentin and Lamotrigine having the highest GP awareness rates. Almost 25% of GPs would initiate treatment following a first time seizure although only 30% would change therapy initiated by a consultant neurologist. Finally the majority of GPs were unhappy with the level of access to neurologists and 95% of GPs felt that the provision of an Epilepsy Clinical Nurse Specialist would help alleviate the problem. |